T1	Participants 74 105	patients with allergic rhinitis
T2	Participants 528 575	patients with persistent allergic rhinitis (AR)
T3	Participants 780 810	40 patients with persistent AR
T4	Participants 1712 1785	patients with AR treated with antihistamines, with or without montelukast
